drugset / Trial / NCT03140319

Transplantation of Fibroblast for Correction of Nasolabial Folds

NCT03140319 ↗

Phase 1/2 Unknown 50 enrolled SCARM Institute, Tabriz, Iran
RandomizedParallel-groupTriple-blindTreatment

Summary

The study evaluated the safety and efficacy of the Autologous cultured fibroblast for correction of Nasolabial folds and inhibition of skin aging

Timeline

Start
2020-12-10
Primary completion
2021-11-15
Completion
2021-12-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibroblast Cell therapy 2e+07 cells Other

Indications